These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9855029)

  • 1. Existing treatment strategies: does noncompliance make a difference?
    Caro JJ; Speckman JL
    J Hypertens Suppl; 1998 Sep; 16(7):S31-4. PubMed ID: 9855029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data.
    Caro JJ; Speckman JL; Salas M; Raggio G; Jackson JD
    CMAJ; 1999 Jan; 160(1):41-6. PubMed ID: 9934342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stepped care for hypertension: are the assumptions valid?
    Caro JJ
    J Hypertens Suppl; 1997 Dec; 15(7):S35-9. PubMed ID: 9532519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study.
    Bourgault C; Sénécal M; Brisson M; Marentette MA; Grégoire JP
    J Hum Hypertens; 2005 Aug; 19(8):607-13. PubMed ID: 15920457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive persistence and drug class.
    Marentette MA; Gerth WC; Billings DK; Zarnke KB
    Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term persistence with antihypertensive drugs in new patients.
    Degli Esposti E; Sturani A; Di Martino M; Falasca P; Novi MV; Baio G; Buda S; Volpe M
    J Hum Hypertens; 2002 Jun; 16(6):439-44. PubMed ID: 12037702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
    Khan NA; McAlister FA; Lewanczuk RZ; Touyz RM; Padwal R; Rabkin SW; Leiter LA; Lebel M; Herbert C; Schiffrin EL; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; DeChamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Campbell NR; Arnold M; Moe G; Hill MD; Jones C; Larochelle P; Ogilvie RI; Tobe S; Houlden R; Burgess E; Feldman RD;
    Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
    Pikilidou MI; Lasaridis AN; Sarafidis PA; Tziolas IM; Zebekakis PE; Dombros NV; Giannoulis E
    Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost analysis of different pharmacological treatment strategies in elderly hypertensives.
    Linjer E; Hedner T; Jönsson B; Ekbom T; Lindholm LH; Dahlöf B; de Faire U; Scherstén B;
    Blood Press; 2005; 14(2):107-13. PubMed ID: 16036488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B
    Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE.
    Düsing R; Handrock R; Klebs S; Tousset E; Vrijens B
    J Hypertens; 2009 Apr; 27(4):894-901. PubMed ID: 19300114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined antihypertensive therapy: review of multicenter studies conducted in foreign countries].
    Shabalin AV; Nikitin IuP
    Ter Arkh; 1999; 71(8):74-8. PubMed ID: 10515043
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison between persistence to therapy in ALLHAT and in everyday clinical practice: a generalizability issue.
    Cardinal H; Monfared AA; Dorais M; LeLorier J
    Can J Cardiol; 2004 Mar; 20(4):417-21. PubMed ID: 15057318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing hypertension management in clinical practice.
    Heagerty A
    J Hum Hypertens; 2006 Nov; 20(11):841-9. PubMed ID: 16915300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
    Roberts ME; Epstein BJ
    J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choice of initial antihypertensive medication and continuation of use.
    Grégoire JP
    Can J Cardiol; 1999 Nov; 15 Suppl F():39F-41F. PubMed ID: 10579751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.